| Control group (N = 47) | Patient group (N = 47) |  |
---|---|---|---|
Age (years) | 71.6 ± 9.1 | 72.7 ± 7.2 | = 0.5160 |
Gender (M/F) | 19/28 | 15/32 | = 0.3910 |
ALT (U/L) | 18 (14–22) | 16 (13–21) | = 0.3040 |
GGT (U/L) | 20 (15–35) | 19 (15–32) | = 0.6270 |
CRP (mg/L) | 4.09 (1.83–7.76) | 5.20 (2.39–10.80) | = 0.3100 |
WBC (×10^9/L) | 7.2 ± 2.0 | 7.4 ± 2.0 | = 0.6120 |
Neutrophyl (×10^9/L) | 4.3 ± 1.8 | 4.5 ± 1.8 | = 0.5880 |
Lymphocyte (×10^9/L) | 2.1 ± 0.7 | 2.1 ± 0.8 | = 0.9360 |
NLR | 2.07 (1.34–2.81) | 2.13 (1.41–3.09) | = 0.5010 |
PLT (×10^9/L) | 216.9 ± 57.4 | 247.2 ± 64.7 | = 0.0250 |
PDW (fL) | 11.5 (11.0–13.3) | 11.7 (10.9–13.3) | = 0.8050 |
MPV (fL) | 10.5 ± 0.9 | 10.3 ± 0.8 | = 0.4810 |
PCT (%) | 0.23 (0.21–0.25) | 0.26 (0.20–0.28) | = 0.1650 |
MPslag time (min) | 12.87 (10.33–15.67) | 12.00 (10.67–14.00) | = 0.5960 |
MPs ETP (nmol/L•min) | 2092.8 ± 676.1 | 2029.5 ± 615.9 | = 0.6450 |
MPsPeak (nmol/L) | 377.43 (294.73–463.98) | 388.27 (315.29–473.32) | = 0.5040 |
MPsttPeak (min) | 15.67 (13.00–19.21) | 14.44 (13.00–16.38) | = 0.2700 |
MPsstartTail (min) | 31 (28–35) | 30 (27–33) | = 0.2730 |